A Randomized, Positive-controlled, Single-dose, Dose-escalation Phase I Trial to Evaluate Safety, Tolerability and Explore the Pharmacokinetics and Pharmacodynamics Profile of Pegylated rhEPO in Male Healthy Individual

Trial Profile

A Randomized, Positive-controlled, Single-dose, Dose-escalation Phase I Trial to Evaluate Safety, Tolerability and Explore the Pharmacokinetics and Pharmacodynamics Profile of Pegylated rhEPO in Male Healthy Individual

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Erythropoietin (Primary)
  • Indications Anaemia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Xiamen Amoytop Biotech
  • Most Recent Events

    • 28 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 04 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top